DNA Electronics has partnered with geneOnyx to offer real-time DNA detection technology for genetics-driven retail services
DNA Electronics, a developer of semiconductor solutions for real-time DNA and RNA detection, has licensed its Genalysis technology platform for rapid, lab-free DNA detection to geneOnyx, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications.
Following a successful evaluation of the DNA Electronics' USB-based Genalysis lab-free platform, the two companies are announcing a commercial license and supply agreement that grants geneOnyx access to DNA Electronics' real-time Genalysis platform for cosmetic applications.
DNA Electronics' Genalysis is a real-time platform for nucleic acid testing, delivering accurate, point-of-need results within 30 minutes using a simple sample processing kit and interchangeable test cartridges plugged into a USB stick or other electronic reader.
It processes a saliva sample from a mouth swab using a sample preparation kit designed for unskilled users which delivers purified, amplification-ready DNA to the CMOS-based test cartridge using just a couple of simple manual steps.
The test cartridge then simultaneously amplifies and detects genetic signatures in the DNA when plugged into a USB stick or other electronic device.
The simple three-step Genalysis process of "swab, twist, test" was designed by DNA Electronics to overcome the fact that most nucleic acid tests, even those described as point-of-care, still require laboratory steps such as pipetting and centrifugation, and use expensive instrumentation.
Commenting on the announcement, Prof Toumazou said: "This agreement makes lab-free semiconductor solutions for DNA analysis a commercial reality for both medical and non-medical markets - from personalised medicine to anti-ageing skincare." He added: "Our partnership with geneOnyx delivers the first in a new breed of fast, user-friendly and consumerised DNA analysis services, and it is a key part of our roadmap to actively work with customers to deliver innovative solutions and services around these ground-breaking on-the-spot tests".
"By making this technology really affordable, we are enabling transformative services for retail "cosmeceutical" markets, wellness applications, pharmaceutical drug response and more." While this licensing and supply agreement launches DNA Electronics in its first non-IVD market for test panels selected by geneOnyx, pilot trials for clinical diagnostics using Genalysis will also begin later this year.
